Review ArticlePathophysiology, Diagnosis, and Treatment of Orthostatic Hypotension and Vasovagal SyncopeMedow, Marvin S. PhD*; Stewart, Julian M. MD, PhD*; Sanyal, Sanjukta MD†; Mumtaz, Arif MD†; Sica, Domenic MD‡; Frishman, William H. MD†Author Information From the Departments of *Pediatrics and †Medicine, New York Medical College/Westchester Medical Center, Valhalla, New York; and ‡Department of Clinical Pharmacology and Hypertension, Medical College of Virginia of Virginia Commonwealth University, Richmond, Virginia. Correspondence: William H. Frishman, MD, Department of Medicine, New York Medical College, Valhalla, NY 10595. E-mail: [email protected]. Cardiology in Review: January 2008 - Volume 16 - Issue 1 - p 4-20 doi: 10.1097/CRD.0b013e31815c8032 Buy Metrics Abstract Orthostatic hypotension (OH) occurs in 0.5% of individuals and as many as 7–17% of patients in acute care settings. Moreover, OH may be more prevalent in the elderly due to the increased use of vasoactive medications and the concomitant decrease in physiologic function, such as baroreceptor sensitivity. OH may result in the genesis of a presyncopal state or result in syncope. OH is defined as a reduction of systolic blood pressure (SBP) of at least 20 mm Hg or diastolic blood pressure (DBP) of at least 10 mm Hg within 3 minutes of standing. A review of symptoms, and measurement of supine and standing BP with appropriate clinical tests should narrow the differential diagnosis and the cause of OH. The fall in BP seen in OH results from the inability of the autonomic nervous system (ANS) to achieve adequate venous return and appropriate vasoconstriction sufficient to maintain BP. An evaluation of patients with OH should consider hypovolemia, removal of offending medications, primary autonomic disorders, secondary autonomic disorders, and vasovagal syncope, the most common cause of syncope. Although further research is necessary to rectify the disease process responsible for OH, patients suffering from this disorder can effectively be treated with a combination of nonpharmacologic treatment, pharmacologic treatment, and patient education. Agents such as fludrocortisone, midodrine, and selective serotonin reuptake inhibitors have shown promising results. Treatment for recurrent vasovagal syncope includes increased salt and water intake and various drug treatments, most of which are still under investigation. © 2008 Lippincott Williams & Wilkins, Inc.